Showing 121-130 of 2123 results for "".
Migraine Mimics
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-mimics/31510/Are we underdiagnosing migraines?Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.Blood Pressure Targets After Stroke: How Low Is Too Low?
https://practicalneurology.com/diseases-diagnoses/stroke/blood-pressure-targets-after-stroke-how-low-is-too-low/49161/Acute hypertensive response management after stroke is a dynamic process that requires careful integration of clinical trial evidence, pathophysiologic principles, imaging findings, and patient-specific factors.Understanding Chiari Malformation Comorbidities
https://practicalneurology.com/diseases-diagnoses/headache-pain/understanding-chiari-malformation-comorbidities/31925/Part 2 of this special report reviews the comorbidities and trauma-related aggravation of Chiari type I malformations.Diagnosing And Treating Co-Morbid Sleep Apnea In Neurological Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/diagnosing-and-treating-co-morbid-sleep-apnea-in-neurological-disorders/30843/Since neurologists are frequently principal care providers for many neurological patients, it is crucial for neurology physicians to be familiar with the identification of sleep apnea. First of a two part series.Onabotulinumtoxin A for Headache: An Update
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-a-for-headache-an-update/30783/A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.Medical Marijuana and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-parkinsons-disease/30245/Given limited treatments available, investigating potential benefits of cannabinoids can offer cautious optimism over controversy.Women & Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/women-epilepsy/31589/Biology unique to female individuals with epilepsy affects disease management significantly.Managing Symptoms of Depression, Apathy, Psychosis, and Agitation in People Living with Alzheimer Disease
https://practicalneurology.com/archives/aug-2025-issue/managing-symptoms-of-depression-apathy-psychosis-and-agitation-in-people-living-with-alzheimer-disease/36689/Optimal treatment of neuropsychiatric symptoms in Alzheimer disease necessitates early identification, rigorous clinical differentiation, and the development of individualized therapeutic approaches.Fluid Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fluid-biomarkers-in-multiple-sclerosis/36255/Fluid biomarkers may allow for improvement in diagnosis, prognostication, and monitoring of disease activity and treatment response in multiple sclerosis while reducing reliance on imaging.